Alzheimer’s Disease: A Comprehensive Overview

The primary factor contributing to dementia, which is defined by a decrease in one's capacity for independent thought and action and everyday actions, is Alzheimer's disease (AD), a syndrome that sources the degradation of mind lockups. The two primary theories proposed as the etiology of AD, a complex sickness, remain the cholinergic and amyloid hypotheses. The disease is influenced by many risk factors, such as aging, inheritances, head trauma, vascular matters, impurities, and ecological variables. Cholinesterase enzyme inhibitors and N-methyl d-aspartate (NMDA) opponents are the only dual forms of approved treatments available to indulge AD at this time. Only AD symptoms can be effectively treated with these drugs. They neither stop nor cure the condition. Over 20 danger features aimed at the Alzheimer's virus were identified in the primary assessments. These included stage, disturbing mind damage, exposure near aluminum, familial inheritance, and related comorbidities such as infection and then vascular illness. This review reexamines these risk variables in light of new data, highlights those that are currently thought to be significant, and explores a number of theories to explain how they might contribute to AD. Both presenilin (PSEN1/2) and amyloid precursor protein (APP) gene mutations are the causative genetic factor changes that stay closely related to rare forms of familial AD with an early onset (EO-FAD). Sporadic AD with late onset (LO-SAD), on the other hand, is a complex condition where age-linked alterations, risk factors related to genetics, including allelomorphic differences in the immune system, infection, metal exposure, vascular disease, traumatic brain damage, apolipoprotein E (Apo E), then various extra DNA segments, and dietary danger features are all concerned.